Concepedia

Author

Junhee Pyo

Tufts Medical CenterORCID

Also Known As

Gunjal, Shalak, J. H. Pyo, J. Pyo, Junhee Pyo, Matthew Chenoweth

51

Publications

1.4K

Citations

20

H-Index

28

Concepts

All Affiliations

Tufts Medical CenterUniversity of UlsanUlsan CollegeAsan Medical CenterDana-Farber Cancer Institute
JP

About

Junhee Pyo is an author at Tufts Medical Center specializing in medicine, public health, and health policy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

95

2

Public Health

3

3

95

3

Health Policy

2

2

42

4

Epidemiology

1

1

53

5

Applied Economics

1

1

11

Junhee Pyo

×

9

Publications

230

Citations

9

H-Index

YearCitations

Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: Exposure prevalence, preterm delivery, and specific birth defects

Carol Louik, Katherine A. Ahrens, Stephen J. Kerr,

Vaccine

2013

53

Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitors

Sang Eun Won, Hyo Jung Park, Sangil Byun,

OncoImmunology

2020

36

Fluid Retention Associated with Imatinib Treatment in Patients with Gastrointestinal Stromal Tumor: Quantitative Radiologic Assessment and Implications for Management

Kyung Won Kim, Atul B. Shinagare, Katherine M. Krajewski,

Korean Journal of Radiology

2015

35

Medicare Is Scrutinizing Evidence More Tightly For National Coverage Determinations

James D. Chambers, Matthew Chenoweth, Michael J. Cangelosi,

Health Affairs

2015

31

Despite High Costs, Specialty Drugs May Offer Value For Money Comparable To That Of Traditional Drugs

James D. Chambers, Teja Thorat, Junhee Pyo,

Health Affairs

2014

28

Performing Gadoxetic Acid–Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis

Chong Hyun Suh, Kyung Won Kim, Seong Ho Park,

American Journal of Roentgenology

2017

14

CCR8 as a Therapeutic Novel Target: Omics-Integrated Comprehensive Analysis for Systematically Prioritizing Indications

Nari Kim, Mi‐Hyun Kim, Junhee Pyo,

Biomedicines

2023

12

The lag from FDA approval to published cost-utility evidence

James D. Chambers, Teja Thorat, Junhee Pyo,

Expert Review of Pharmacoeconomics & Outcomes Research

2015

11

Comprehensive Analysis for Anti-Cancer Target-Indication Prioritization of Placental Growth Factor Inhibitor (PGF) by Use of Omics and Patient Survival Data

Nari Kim, Yousun Ko, Youngbin Shin,

Biology

2023

10

Page 1